oa Journal of Endocrinology, Metabolism and Diabetes in South Africa - Cannabinoid antagonist in obesity treatment : commentary on a clinical trial

Volume 14, Issue 2
  • ISSN : 1608-9677
  • E-ISSN: 2220-1009



CP-945.598 is an orally active selective antagonist of the cannabinoid CB-1 receptor that has been developed for weight loss and the prevention of weight regain in obese and overweight individuals.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error